Category: Human Bnp

heraeus-targets

Bacterial CellCultures in a Lab-on-a-Disc: a Easy and Versatile Device for Quantification of Antibiotic Remedy EfficacyBacterial CellCultures in a Lab-on-a-Disc: a Easy and Versatile Device for Quantification of Antibiotic Remedy Efficacy

Pathogenic bacterial biofilms shall be life threatening, tremendously decrease affected particular person’s prime quality of life and are a substantial burden on the healthcare system. Current methods for evaluation of

heraeus-targets

Impact of postoperative dexamethasone on survival, steroid dependency, and infections in newly diagnosed glioblastoma patientsImpact of postoperative dexamethasone on survival, steroid dependency, and infections in newly diagnosed glioblastoma patients

Background: We examined the impact of dexamethasone prescribed within the preliminary three postoperative weeks on survival, steroid dependency, and an infection in glioblastoma sufferers. Strategies: On this single-center retrospective cohort evaluation, we

heraeus-targets

Effects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exerciseEffects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exercise

Introduction: Emicizumab (Hemlibra: Roche Switzerland) is a, humanized, bi-specific monoclonal modified immunoglobulin G4 (IgG4) which binds human FX, FIX and activated FIX (FIXa) to imitate activated FVIII exercise. Intention: Consider the consequences

heraeus-targets

Performance of a scalable RNA extraction-free transcriptome profiling method for adherent cultured human cellsPerformance of a scalable RNA extraction-free transcriptome profiling method for adherent cultured human cells

RNA sequencing allows high-content/high-complexity measurements in small molecule screens. Whereas the prices of DNA sequencing and RNA-seq library preparation have decreased constantly, RNA extraction stays a big bottleneck to scalability.